The original sins of clinical trials with intravenous immunoglobulins in sepsis

[1]  J. Vincent,et al.  Annual Update in Intensive Care and Emergency Medicine 2023 , 2014, Annual Update in Intensive Care and Emergency Medicine.

[2]  R. Herrán-Monge,et al.  Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis , 2014, Journal of internal medicine.

[3]  O. Liesenfeld,et al.  Molecular diagnosis of sepsis: New aspects and recent developments. , 2014, European journal of microbiology & immunology.

[4]  R. Herrán-Monge,et al.  Circulating neutrophil counts and mortality in septic shock , 2014, Critical Care.

[5]  L. Dans,et al.  Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. , 2013, The Cochrane database of systematic reviews.

[6]  M. Dostál,et al.  Presence of hypogammaglobulinemia - a risk factor of mortality in patients with severe sepsis, septic shock, and SIRS. , 2013, Prague medical report.

[7]  M. Aman,et al.  Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. , 2012, The Journal of infectious diseases.

[8]  M. Bianchi,et al.  Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis. , 2012, Journal of critical care.

[9]  M. Singer,et al.  Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective , 2012, Critical Care.

[10]  M. Päsler,et al.  Hypogammaglobulinemia in Sepsis , 2012 .

[11]  C. Malcus,et al.  Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. , 2011, International immunopharmacology.

[12]  J. Eiros,et al.  Early natural killer cell counts in blood predict mortality in severe sepsis , 2011, Critical care.

[13]  J. Vincent,et al.  &ggr;-GLOBULIN LEVELS IN PATIENTS WITH COMMUNITY-ACQUIRED SEPTIC SHOCK , 2009, Shock.

[14]  A. Nierhaus,et al.  Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock * , 2007, Critical care medicine.

[15]  R. Schmieder,et al.  Score‐based immunoglobulin G therapy of patients with sepsis: The SBITS study * , 2007, Critical care medicine.

[16]  L. Dans,et al.  Intravenous immunoglobulin for treating sepsis and septic shock. , 2002, The Cochrane database of systematic reviews.